Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort studyFrancesco Passamonti, Celestino Ferrandina, Daniele Vallisa et al.|The Lancet Haematology|2020Cited by 553
Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term OutcomeFederico Lussana, Alessandro Rambaldi, Tamara Intermesoli et al.|Transplantation and Cellular Therapy|2016Cited by 88
Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemiaRenato Bassan, Alessandro Rambaldi, Orietta Spinelli et al.|Blood Cancer Journal|2014Cited by 63
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use programFabio Guolo, Roberto M. Lemoli, Luana Fianchi et al.|Blood Cancer Journal|2020Cited by 58
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07Renato Bassan, Alessandro Rambaldi, Chiara Pavoni et al.|Blood Cancer Journal|2020Cited by 45